These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34055811)

  • 1. Corrigendum: Inhibition of TGF-β/Smad3 Signaling Disrupts Cardiomyocyte Cell Cycle Progression and Epithelial-Mesenchymal Transition-Like Response During Ventricle Regeneration.
    Peng Y; Wang W; Fang Y; Hu H; Chang N; Pang M; Hu YF; Li X; Long H; Xiong JW; Zhang R
    Front Cell Dev Biol; 2021; 9():699796. PubMed ID: 34055811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TGF-β/Smad3 Signaling Disrupts Cardiomyocyte Cell Cycle Progression and Epithelial-Mesenchymal Transition-Like Response During Ventricle Regeneration.
    Peng Y; Wang W; Fang Y; Hu H; Chang N; Pang M; Hu YF; Li X; Long H; Xiong JW; Zhang R
    Front Cell Dev Biol; 2021; 9():632372. PubMed ID: 33816481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
    Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elf5 inhibits TGF-β-driven epithelial-mesenchymal transition in prostate cancer by repressing SMAD3 activation.
    Yao B; Zhao J; Li Y; Li H; Hu Z; Pan P; Zhang Y; Du E; Liu R; Xu Y
    Prostate; 2015 Jun; 75(8):872-82. PubMed ID: 25728398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
    Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
    Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Catenin/Smad3 Interaction Regulates Transforming Growth Factor-β-Induced Epithelial to Mesenchymal Transition in the Lens.
    Taiyab A; Holms J; West-Mays JA
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation status at Smad3 linker region modulates transforming growth factor-β-induced epithelial-mesenchymal transition and cancer progression.
    Ooshima A; Park J; Kim SJ
    Cancer Sci; 2019 Feb; 110(2):481-488. PubMed ID: 30589983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Starvation-induced autophagy promotes the invasion and migration of human bladder cancer cells via TGF-β1/Smad3-mediated epithelial-mesenchymal transition activation.
    Tong H; Yin H; Hossain MA; Wang Y; Wu F; Dong X; Gao S; Zhan K; He W
    J Cell Biochem; 2019 Apr; 120(4):5118-5127. PubMed ID: 30320898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ShcA Protects against Epithelial-Mesenchymal Transition through Compartmentalized Inhibition of TGF-β-Induced Smad Activation.
    Muthusamy BP; Budi EH; Katsuno Y; Lee MK; Smith SM; Mirza AM; Akhurst RJ; Derynck R
    PLoS Biol; 2015 Dec; 13(12):e1002325. PubMed ID: 26680585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad3 linker phosphorylation attenuates Smad3 transcriptional activity and TGF-β1/Smad3-induced epithelial-mesenchymal transition in renal epithelial cells.
    Bae E; Kim SJ; Hong S; Liu F; Ooshima A
    Biochem Biophys Res Commun; 2012 Oct; 427(3):593-9. PubMed ID: 23022526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.
    Zhang J; Thorikay M; van der Zon G; van Dinther M; Ten Dijke P
    J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-135-5p inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by targeting SMAD3 in breast cancer.
    Yang W; Feng W; Wu F; Gao Y; Sun Q; Hu N; Lu W; Zhou J
    J Cancer; 2020; 11(21):6402-6412. PubMed ID: 33033523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
    Da C; Liu Y; Zhan Y; Liu K; Wang R
    Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
    Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial to mesenchymal transition in Madin-Darby canine kidney cells is accompanied by down-regulation of Smad3 expression, leading to resistance to transforming growth factor-beta-induced growth arrest.
    Nicolás FJ; Lehmann K; Warne PH; Hill CS; Downward J
    J Biol Chem; 2003 Jan; 278(5):3251-6. PubMed ID: 12435725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
    Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
    Wang B; Liu T; Wu JC; Luo SZ; Chen R; Lu LG; Xu MY
    Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits migration and invasion through Epithelial-Mesenchymal-Transition in lung cancer.
    Hao Y; Yang X; Zhang D; Luo J; Chen R
    Gene; 2017 Apr; 608():1-12. PubMed ID: 28119085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.